Toxicity of Bevacizumab in Combination with Chemotherapy in Older Patients

BACKGROUND. Bevacizumab leads to improved survival for patients with metastatic colorectal cancer (CRC) or non-small cell lung cancer (NSCLC) when added to chemotherapy. Little is known about factors associated with receipt of bevacizumab, or whether bevacizamab is associated with increased toxicity...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Mohile, Supriya G., Hardt, Molly, Tew, William, Owusu, Cynthia, Klepin, Heidi, Gross, Cary, Gajra, Ajeet, Lichtman, Stuart M., Feng, Tao, Togawa, Kayo, Ramani, Rupal, Katheria, Vani, Hansen, Kurt, Hurria, Arti
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AlphaMed Press 2013
Konular:
Geriatric Oncology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3639527/
https://ncbi.nlm.nih.gov/pubmed/23576485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0351
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller